Jupiter Research Capital (Asia) Ltd’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Jupiter Research Capital (Asia) Ltd's WST Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 2,068 shares — an estimated $742K sold.
Jupiter Research Capital (Asia) Ltd first reported a position in WST in Q2 2026 and held it in 1 quarter. The position peaked at $742K in Q2 2026. 830 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 2,068 West Pharmaceutical shares in Q3 2026, an estimated $742K.
- Jupiter Research Capital (Asia) Ltd first reported a position in West Pharmaceutical in Q2 2026 and held it in 1 quarter.
- Jupiter Research Capital (Asia) Ltd's West Pharmaceutical position peaked at $742K in Q2 2026.
- 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.